Showing results (131-140 of 244) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival dataJean-Yves Pierga, Thierry Petit, Christelle Lévy, et al.
International Journal of Cancer|August 13, 2013
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanomaFrançois-Clément Bidard, Jordan Madic, Pascale Mariani, et al.
Scientific Reports|November 7, 2025
Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie HospitalsAlexandre De Moura, Orane Gleizes, Luc Cabel, et al.
British Journal of Clinical Pharmacology|January 6, 2011
Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patientsMarie-Christine Etienne-Grimaldi, Patricia Formento, Armelle Degeorges, et al.
Cancers|January 9, 2021
The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer SubtypesLucie Laot, Enora Laas, Noemie Girard, et al.
Cancers|March 24, 2019
Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer PatientsLuc Cabel, Charles Decraene, Ivan Bieche, et al.
Plos One|July 9, 2016
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant ChemotherapyHélène Bonsang-Kitzis, Léonor Chaltier, Lisa Belin, et al.
Anticancer Research|March 19, 2017
First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational StudyVeronique Dieras, Simona Pop, Frederique Berger, et al.
Oncogene|February 27, 2024
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysisAntoine Vasseur, Luc Cabel, Caroline Hego, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arraysAntoine-Emmanuel Saliba, Laure Saias, Eleni Psychari, et al.
Pageof 25